Upgrade to SI Premium - Free Trial

H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

July 31, 2026 6:41 AM
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating and $485.00 price target on Alnylam Pharmaceuticals (NASDAQ: ALNY).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles